XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 6 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income $ 12,397 $ 3,574
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for loan losses 1,400 300
Depreciation and amortization 819 698
Net gain on sale of securities available for sale (105) (240)
Stock-based compensation 679 445
Net gain on sale of loans held-for-sale (3,067) (476)
Net accretion of premiums, discounts and loan fees and costs (2,743) (229)
Amortization of intangible assets 42 2
Amortization of debt issuance costs 28 43
Loan servicing rights valuation adjustments 235 25
Deferred tax expense (benefit) 978 (170)
Decrease in accrued interest receivable 1,469 276
Increase in other assets (438) (2,196)
(Decrease) increase in accrued interest payable (310) 414
(Decrease) increase in other liabilities (1,678) 25
Net cash provided by operating activities 9,706 2,491
Cash flows from investing activities:    
Purchases of securities available for sale 0 (4,700)
Purchases of restricted securities (1,157) (223)
Proceeds from sales of securities available for sale 2,105 3,240
Principal repayments of securities held to maturity 3,978 1,247
Principal repayments of securities available for sale 298 18
Redemptions of restricted securities 1,259 601
Proceeds from sales of loans 54,512 18,287
Net increase in loans (91,406) (57,026)
Purchases of premises and equipment (649) (870)
Net cash used in investing activities (31,060) (39,426)
Cash flows from financing activities:    
Net increase in deposits 66,225 53,424
Advances of term FHLB borrowings 20,000 0
Repayments of FHLB advances (24,000) (12,580)
Repayments of Federal Reserve Bank borrowings (79,729) (16,157)
Proceeds from issuance of subordinated debentures, net of issuance costs 0 24,455
Repayment of note payable 0 (15,000)
Cash dividends paid (588) 0
Net proceeds from issuance of common stock 42 113
Net cash (used in) provided by financing activities (18,050) 34,255
Net decrease in cash and cash equivalents (39,404) (2,680)
Cash and cash equivalents, beginning of period 166,544 80,209
Cash and cash equivalents, end of period 127,140 77,529
Supplemental cash flow information:    
Interest paid 2,854 3,334
Income taxes paid 4,071 514
Supplemental non-cash disclosure:    
Transfers from portfolio loans to loans held-for-sale $ 51,445 $ 18,704